Evidence map›Paper›PMID 26424796›Full record

ArticleThe Journal of biological chemistry2015

Adrenocorticotropic Hormone (ACTH) Responses Require Actions of the Melanocortin-2 Receptor Accessory Protein on the Extracellular Surface of the Plasma Membrane.

Sundeep Malik, Terrance M Dolan, Zachary J Maben, Patricia M Hinkle

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Transgenerational hypocortisolism and behavioral disruption are induced by the antidepressant fluoxetine in male zebrafishProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. ACTH Antagonists.Frontiers in endocrinology · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sundeep MalikFrom the Department of Pharmacology and Physiology, University of Rochester Medical Center Rochester, New York 14642.
Terrance M DolanFrom the Department of Pharmacology and Physiology, University of Rochester Medical Center Rochester, New York 14642.
Zachary J MabenFrom the Department of Pharmacology and Physiology, University of Rochester Medical Center Rochester, New York 14642.
Patricia M HinkleFrom the Department of Pharmacology and Physiology, University of Rochester Medical Center Rochester, New York 14642 patricia_hinkle@urmc.rochester.edu.
University of Rochester Medical Center · US

Funding

MODULATION OF RECEPTOR NUMBER IN CULTURED CELLSR01DK019974 · NIDDK · UNIVERSITY OF ROCHESTER · PI HINKLE, PATRICIA M. · 1986 to 2011
$4.1M
Functions of the Human OST-alpha and OST-beta ProteinsR01DK067214 · NIDDK · UNIVERSITY OF ROCHESTER · PI HINKLE, PATRICIA M. · 2005 to 2013
$2.8M
NIDDK NIH HHS DK19974NIDDK NIH HHS DK67214NIDDK NIH HHS R01 DK019974NIDDK NIH HHS R01 DK067214
6 · The paper itself

Abstract

The melanocortin-2 (MC2) receptor is a G protein-coupled receptor that mediates responses to ACTH. The MC2 receptor acts in concert with the MC2 receptor accessory protein (MRAP) that is absolutely required for ACTH binding and signaling. MRAP has a single transmembrane domain and forms a highly unusual antiparallel homodimer that is stably associated with MC2 receptors at the plasma membrane. Despite the physiological importance of the interaction between the MC2 receptor and MRAP, there is little understanding of how the accessory protein works. The dual topology of MRAP has made it impossible to determine whether highly conserved and necessary regions of MRAP are required on the intracellular or extracellular face of the plasma membrane. The strategy used here was to fix the orientation of two antiparallel MRAP molecules and then introduce inactivating mutations on one side of the membrane or the other. This was achieved by engineering proteins containing tandem copies of MRAP fused to the amino terminus of the MC2 receptor. The data firmly establish that only the extracellular amino terminus (Nout) copy of MRAP, oriented with critical segments on the extracellular side of the membrane, is essential. The transmembrane domain of MRAP is also required in only the Nout orientation. Finally, activity of MRAP-MRAP-MC2-receptor fusion proteins with inactivating mutations in either MRAP or the receptor was rescued by co-expression of free wild-type MRAP or free wild-type receptor. These results show that the basic MRAP-MRAP-receptor signaling unit forms higher order complexes and that these multimers signal.

Indexed as

Adrenocorticotropic HormoneAmino Acid SequenceCell MembraneHEK293 CellsHumansMembrane ProteinsMolecular Sequence DataMutationProtein EngineeringProtein MultimerizationProtein Structure, TertiaryRecombinant Fusion ProteinsSignal TransductionAdrenocorticotropic HormoneMembrane ProteinsMRAP protein, humanRecombinant Fusion Proteinsaccessory proteinadrenocorticotropic hormone (ACTH)cyclic AMP (cAMP)G protein-coupled receptor (GPCR)melanocortin receptormelanocortin receptor accessory protein (MRAP)membrane proteinmembrane protein topologysignal transductiontransmembrane domain

Identifiers

PMID26424796
PMCPMC4646036
OpenAlexW2177303033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.